Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C CirrhosisGeorge N. Ioannou, Akbar K. Waljee, Weijing Tang et al.|JAMA Network Open|2020Cited by 160
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitisMonica A. Tincopa, Rohit Loomba|The Lancet. Gastroenterology & hepatology|2023Cited by 144
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysisNaba Saeed, Monica A. Tincopa, Lisa Glass et al.|Transplantation|2019Cited by 125
New and emerging treatments for metabolic dysfunction-associated steatohepatitisMonica A. Tincopa, Rohit Loomba, Quentin M. Anstee|Cell Metabolism|2024Cited by 100
Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fractionAlexandria Miller, Monica A. Tincopa, Jennifer McNamara et al.|Scientific Reports|2020Cited by 80